The World Health Assembly recently release a document indicating the importance of newborn screening.

This document calls for coordinated efforts to accelerate progress toward reducing maternal and child mortality. It urges the prioritization of improvements in sexual, reproductive, maternal, newborn, and adolescent health services, strengthen the health workforce, and to enhance access to essential medicines. The release also highlights the importance of integrating water, sanitation, and hygiene into health systems, with a focus on underserved populations. CLSI is here to offer support for these improvements; particularly in newborn screening, through our array of newborn screening documents. NBS01 Dried Blood Spot Specimen Collection for Newborn Screening, NBS02 Newborn Screening Follow-up and Education, and NBS03 Newborn Screening for Preterm, Low Birth Weight, and Sick Newborn lay the foundation for collecting and testing newborn screening specimens.

Currently there are three near completed newborn screening documents in development from CLSI to help the World Health Assembly accomplish their mission:

• NBS11 NBS for Congenital Adrenal Hyperplasia
• NBS12 Newborn Screening for Galactosemia
• NBS06 NBS for SCID and Other Related Severe Immunodeficiencies: second edition

These three documents will be published and available in early 2025, and will be joined soon by the several other newborn screening documents in earlier stages of development!